UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
Pursuant to Section 13 or 15(d) of the |
Date of Report: May 05, 2014
(Date of earliest event reported)
Atrion Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction
of incorporation)
0-10763
(Commission File Number)
63-0821819
(IRS Employer
Identification Number)
One Allentown Parkway, Allen, Texas
(Address of principal executive offices)
75002
(Zip Code)
972-390-9800
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if changed since last report)
|
Item 2.02. Results of Operations and Financial Condition On May 5, 2014, Atrion Corporation (the "Company"), issued a press release entitled, "Atrion Reports First Quarter Results." A copy of the press release issued by the Company is furnished herewith as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Dated: May 05, 2014 |
ATRION CORPORATION
By: /s/ David A. Battat |
|
|
|
| Exhibit No. | Description |
| 99.1 | Press Release of Atrion Corporation dated May 05, 2014 |
ALLEN, TX -- (Marketwired - May 05, 2014) - Atrion Corporation (NASDAQ: ATRI) today announced diluted earnings per share for the first quarter of 2014 were up 10% to $3.61 as compared to $3.28 in the first quarter of 2013.
Atrion's revenues for the quarter ended March 31, 2014 were $36,419,000 compared with $33,493,000 in the same period in 2013. Net income in the current-year quarter totaled $7,201,000 compared to $6,635,000 in last year's first quarter.
Commenting on the Company's results for the first quarter of 2014 compared to the same period last year, David A. Battat, President & CEO, said, "We are pleased with the significant increase in revenues, with solid growth in our cardiovascular and fluid delivery product lines. Overall, compared to the same quarter last year, revenues were up 9%, operating income was up 14%, and diluted EPS increased 10%. The EPS comparisons are skewed due to Congress's persistently inconsistent timing in extending R&D tax credits. Five quarters worth of R&D tax credits had to be recorded in the first quarter of 2013, while no credits could be booked in the just finished quarter." Mr. Battat added, "During the quarter we invested $4.7 million to purchase 15,142 shares of our common stock, while continuing to be debt free as well as having $55.0 million in cash and short and long term investments at the end of the quarter."
Atrion Corporation develops and manufactures products primarily for medical applications. The Company's website is www.atrioncorp.com.
ATRION CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended
March 31,
2014 2013
----------- -----------
Revenues $ 36,419 $ 33,493
Cost of goods sold 19,031 17,784
----------- -----------
Gross profit 17,388 15,709
Operating expenses 6,688 6,309
----------- -----------
Operating income 10,700 9,400
Interest income 300 350
Other income (expense), net 1 --
----------- -----------
Income before income taxes 11,001 9,750
Income tax provision (3,800) (3,115)
----------- -----------
Net income 7,201 6,635
=========== ===========
Income per basic share $ 3.63 $ 3.28
=========== ===========
Weighted average basic shares outstanding 1,982 2,020
=========== ===========
Income per diluted share $ 3.61 $ 3.28
=========== ===========
Weighted average diluted shares outstanding 1,997 2,024
=========== ===========
ATRION CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)
Mar. 31, Dec. 31,
ASSETS 2014 2013
----------- -----------
(Unaudited)
Current assets:
Cash and cash equivalents $ 17,196 $ 28,559
Short-term investments 25,417 18,351
----------- -----------
Total cash and short-term investments 42,613 46,910
Accounts receivable 18,642 14,164
Inventories 26,326 26,266
Prepaid expenses and other 1,008 1,603
Deferred income taxes 1,376 1,376
----------- -----------
Total current assets 89,965 90,319
Long-term investments 12,375 10,069
Property, plant and equipment, net 59,580 58,328
Other assets 13,280 13,350
----------- -----------
$ 175,200 $ 172,066
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities 11,636 9,364
Line of credit -- --
Other non-current liabilities 12,934 13,708
Stockholders' equity 150,630 148,994
----------- -----------
$ 175,200 $ 172,066
=========== ===========
Contact: Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800